Biotech Values

[DewDiligence]

NABI, Biota amend terms of merger:

http://finance.yahoo.com/news/nabi-biopharmaceuticals-biota-holdings-limited-214628422.html

The revisions to the terms of the Transaction serve, in part, to address the fact that, since the Transaction was first announced in April 2012, the market value of Biota's outstanding shares has declined. The Board of Directors of Nabi believes that, by increasing the cash return to Nabi stockholders and linking the number of shares of Nabi common stock that Biota stockholders will receive in the Transaction to Biota's stock price, Nabi's stockholders will receive additional value in the Transaction.